Restless Legs Syndrome (RLS) Clinical Trial
Official title:
A Double-Blinded, Multi-Center, Randomized, Placebo-Controlled Study to Investigate the Efficacy and Safety of Injectafer (Ferric Carboxymaltose) in the Treatment of Restless Legs Syndrome (RLS)
This will be a Phase III, double blinded, multi-center, randomized, placebo-controlled study. Eligible subjects will be randomized in a 1:1 ratio to receive Injectafer or Placebo on days 0 and 5. All treated subjects will be followed for efficacy and safety for 12 months. The subject's participation in the study will be for approximately 1 year from Day 0.
This will be a Phase III, double blinded, multi-center, randomized, placebo-controlled study. Eligible subjects will be randomized in a 1:1 ratio to receive Injectafer or Placebo on days 0 and 5. All treated subjects will be followed for efficacy and safety for 12 months. Subjects will visit the clinic on Days 0 and 5 for treatment, and then on Days 14, 42, 168, and 365. In between the clinic visits subjects will be contacted remotely on Days 84, 126, 210, 252, 294, and 336. The subject's participation in the study will be for approximately 1 year from Day 0. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00748098 -
Polysomnography Study of GSK1838262 Extended Release Tablets Versus Placebo in RLS and Associated Sleep Disturbance
|
Phase 3 | |
| Completed |
NCT00373542 -
12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
|
Phase 4 | |
| Completed |
NCT01981941 -
Post-marketing Study of Gabapentin Enacarbil to Evaluate the Effect in Restless Leg Syndrome (RLS) Patients With Moderate Renal Impairment
|
Phase 4 | |
| Completed |
NCT01823770 -
Effect of Rotigotine Patch Treatment on Cardiovascular Markers in Idiopathic Restless Legs Syndrome
|
Phase 4 | |
| Completed |
NCT00256854 -
Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome)
|
Phase 3 | |
| Completed |
NCT03053427 -
A Study of Oral Dosing of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients
|
Phase 4 | |
| Completed |
NCT01382901 -
Intravenous (IV) Iron Preparation (VIT-45) in the Treatment of Restless Legs Syndrome (RLS)
|
Phase 2 | |
| Completed |
NCT01411124 -
Study to Assess the Effect of Gabapentin Enacarbil on Simulated Driving in Healthy Subjects
|
Phase 1 | |
| Terminated |
NCT02826681 -
Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia
|
Phase 2 | |
| Completed |
NCT01494766 -
Efficacy of Tyrosine in Restless Legs Syndrome
|
N/A | |
| Completed |
NCT00314860 -
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
|
Phase 3 | |
| Completed |
NCT00363857 -
A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome
|
Phase 3 |